Search for: "Michael B. Johnson"
Results 421 - 440
of 630
Sorted by Relevance
|
Sort by Date
30 Oct 2022, 5:54 pm
BBC News presenter Martine Croxall has been taken off air amid claims that she showed bias after Boris Johnson pulled out of the Tory leadership contest. [read post]
30 Apr 2012, 11:19 am
Gagain, Michael. [read post]
17 Mar 2011, 9:59 am
Bâli (UCLA) and Rose Gottemoeller (Assistant Secretary of State, Bureau of Verification, Compliance, and Implementation). ? [read post]
17 Jul 2012, 8:46 am
Quote from Michael Green’s’ The Unappreciated Congruity of the Second and Third Restatements on Design Defects (2009). [read post]
4 Oct 2008, 9:00 am
For the reasons set forth below, we AFFIRM the judgment of the district court. 08a0595n.06 Michael Johnson v. [read post]
20 Mar 2008, 10:56 am
Johnson, and Jeffery A. [read post]
6 May 2019, 12:05 pm
§ 924(e)(2)(B)(i) and those analyzed as “enumerated offenses” under 18 U.S.C. [read post]
21 Mar 2012, 3:41 am
Johnson, the 2010 decision altering the law regarding merger. [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
30 Nov 2020, 2:08 pm
Johnson and published by Bankrate on September 25, 2020. [read post]
29 Feb 2024, 7:15 pm
Michael A. [read post]
27 Feb 2009, 7:00 am
(IP ADR Blog) Global - Trade Marks / Brands Business superbrands – Google scoops the latest poll (Class 46) Global - Patents Innovation policy: the balance between standards and patent regulation (Intellectual Property Watch) IBM develops patent quality index tool (Competitive Info) Nichia and Seoul to end global LED patent wars (Green Patent Blog) Global - Copyright The Commons video (Creative Commons) Africa Egypt and Nigeria suggested for USTR… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells… [read post]
16 Feb 2011, 2:16 pm
L. 147-150 (2010).CELL TOWERS.Foster, Robert B. [read post]
8 Nov 2023, 5:31 am
Johnson, 1860. [read post]
29 Mar 2013, 2:00 pm
More specifically, the Restatement (Third) of Torts: Products Liability, § 2(b) states, in pertinent part, that a product is defective in design when the foreseeable risks of harm posed by the product could have been reduced or avoided by the adoption of a reasonable alternative design by the seller or other distributor, or a predecessor in the commercial chain of distribution, and that the omission of the alternative design renders the product not reasonably safe. [read post]
29 Aug 2008, 1:25 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC sets strict standards to establish inequitable conduct: Star Scientific v R J Reynolds Tobacco: (Hal Wegner), (Maryland Intellectual Property Law Blog), (Patent Prospector), (Patent Docs), (Patently-O), (more from Patently-O), (Philip Brooks), (Law360), (I/P Updates), Safe harbour ruling in Io v Veoh could help YouTube in Viacom battle: (Ars… [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC) Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]
8 Jan 2017, 4:05 pm
Larose and Michael B. [read post]
15 Nov 2010, 4:18 am
Fairbanks Scales Inc et al (EDTexweblog.com) District Court W D North Carolina: When an assignor is not stopped: Borgwarmer v Honeywell (Property, intangible) Bull in Bilski’s china shop: B of A’s financial instrument: Ex Parte Birle (12:01 Tuesday) District Court S D Florida: Court labels claims transformed in patent reexamination mere disguise: Aspex Eyewear v Marchon Eyewear (Patents Post Grant Blog) District Court S D California: ‘Unreasonable,’… [read post]
